Biotech stocks Akero Therapeutics and 89bio rocketed Monday after the former announced promising test results for a liver disease treatment.

The post Akero Rockets 27%, Prodding Rival 89bio Higher, On Promising Liver Disease Treatment appeared first on Investor’s Business Daily.